Actinium Pharmaceuticals, Inc. 4
4 · Actinium Pharmaceuticals, Inc. · Filed Apr 18, 2016
Insider Transaction Report
Form 4
DAVE KAUSHIK J
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2016-04-14$2.02/sh+8,000$16,160→ 86,500 total - Award
Options to purchase common stock
2016-04-15$1.99/sh+400,000$796,000→ 400,000 totalExercise: $1.99Exp: 2026-04-15→ Common Stock (400,000 underlying) - Purchase
Common Stock
2016-04-14$2.01/sh+2,000$4,020→ 88,500 total
Footnotes (1)
- [F1]Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options shall vest each month from the date of grant.